Zentalis Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.29

+0.15 (+7.01%)

As of Mar 31, 3:11 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 9 60%

Hold 6 40%

Sell 0 0%

Price Target

Analyst Price Target +1,083.0% upside

Low Target $17.95

Average Target $27.09

High Target $27.14

Current Price $2.29

Current
$2.29

Target
$27.09

$17.95 $27.09 avg $27.14

Scenario Analysis

Bear Case

$17.95

683.8%

Low target

Base Case

$27.09

+1,083.0%

Avg target

Bull Case

$27.14

+1,085.2%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$3.95

-42.0% from high

52-Week Low

$1.01

+126.7% from low

Target vs 52W High

$27.09

+585.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%